Pancreatic Cancer Research

Clinical trialPhase 4Unknown

The Effect of Application of TachoSil® in Pancreatoduodenectomy

The Effect of Application of Fibrinogen/Thrombin-coated Collagen Patch (TachoSil®) in Pancreaticojejunostomy for Prevention of Pancreatic Fistula After Pancreatoduodenectomy

Outcome
Outcome unknown
Phase
Phase 4
Status
Unknown
Study type
Interventional
Start
27 February 2017
Listed end
May 2018
Enrollment
126 participants
Sites
1
Primary outcomes
Incidence of pancreatic fistula; Incidence of clinically relevant pancreatic fistula
Sponsor type
Academic / other
Results posted
No
Last update
1 September 2017

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Fibrinogen/thrombin-coated collagen patch (TachoSil®) is known to have the effect of strengthening tissue anastomosis and promoting suturing to prevent leakage. The purpose of this study is to compare the incidence of pancreatic fistula that is most crucial for surgical outcome and complications in pancreaticoduodenectomy with those of the control group and the TachoSil® apply group. Patients who were planned to undergo pancreaticoduodenectomy without a history of chronic pancreatitis are enrolled in this open-label, single-center, randomized, single-blind, phase 4 clinical trial.